SAHPRA Tag

Name: Webinar on Strengthening Regulatory Oversight Through Improved Manufacturer Visibility
Start: 2026-07-29T15:00:00+02:00
End: 2026-07-29T17:00:00+02:00
Location: Virtual

08 May Launch of the Prescription-Only Medicines Section – SAHPRA Online Medicines Directory

Posted at 20:16h in

The South African Health Products Regulatory Authority (SAHPRA) held the official online launch of the Prescription-Only Medicines (Rx) Section of the SAHPRA Online Medicines Directory. SAHPRA had previously successfully launched the Over-the-Counter (OTC) Online Medicines Directory in June 2022 as the first phase of this initiative. The...

28 Apr Industry Webinar on Upcoming Medical Devices Voluntary Feasibility Study – Phase Two

Posted at 13:26h in

The South African Health Products Regulatory Authority (SAHPRA) hosted a workshop on the Medical Devices Voluntary Product Registration Feasibility Study – Phase Two. The purpose of the workshop was to engage stakeholders and discuss the Expression of Interest (EOI) process for participation in the voluntary Phase...

12 Apr Industry Meeting on Adverse Event Reporting for Medical Devices (including IVDs)

Posted at 09:19h in

The South African Health Products Regulatory Authority (SAHPRA) hosted an engagement session focused on training and guidance regarding SAHPRA’s requirements for Adverse Event reporting. The purpose of the engagement was to enhance industry understanding and facilitate the effective implementation of Regulation 17 of the Regulations Relating...

12 Apr Industry Meeting to receive input from applicants on the functionality of the Digital CTF1 Application Module

Posted at 09:15h in

The South African Health Products Regulatory Authority (SAHPRA) hereby invites industry stakeholders to a consultative meeting aimed at receiving updates and feedback from applicants on the functionality of the Digital CTF1 Application Module. The purpose of this engagement is to provide a platform for industry to share...

25 Mar Orientation Webinar on the SAHPRA Portal for New Clinical Trials Application Users

Posted at 09:10h in

The South African Health Products Regulatory Authority (SAHPRA) hosted a follow-up webinar to guide applicants through key functions on the SAHPRA Portal related to Clinical Trials applications. This practical orientation session assisted users in navigating the system effectively and completing the required actions. Topics Covered: Orientation...

RESOLUTE: Dr. Boitumelo Semete – Makokotlela, CEO of SAHPRA, addressing the media in Pretoria.

24 Mar SAHPRA Recalls Affected batches of Citro-Soda Regular Following Safety Concerns

Posted at 17:40h in News & Updates, Press Releases

Pretoria, 24 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) today briefed members of the media on the recall of specific batches of Citro-Soda Regular products, reaffirming its commitment to protecting public health and ensuring the safety, quality, and efficacy of all...

SnerdCo via Adobe Stock

20 Mar SAHPRA to brief media on the recall of specified batches of Citro-Soda Regular amid safety concerns

Posted at 15:55h in Media Advisory, News & Updates, Press Releases

Pretoria, 20 March 2026 – The South African Health Products Regulatory Authority (SAHPRA) will brief the media on the recall of specific batches of Citro-Soda Regular following a potential contamination risk identified at the Adcock Ingram Clayville manufacturing facility in Johannesburg. The recall is limited to...

04 Mar Clinical Trials (Orthodox Medicines): Digital CTF1 Module & Pilot Briefing

Posted at 10:52h in

SAHPRA hosted a consultative meeting with industry stakeholders to share key updates on the development of the Digital CTF1 Application Module and to provide information regarding the planned pilot phase. The session included project progress updates, a system demonstration, and an opportunity for attendees to...

03 Mar SAHPRA’s Regulatory Technical Forum (RTF) Virtual Meeting – March 2026

Posted at 08:55h in

The South African Health Products Regulatory Authority (SAHPRA) hosted the Regulatory Technical Forum (RTF) Meeting. Areas of discussion on the agenda included: Veterinary Medicines Medical devices & IVDs Complementary medicines Medicines (Allopathic) Inspectorate Updates Inspectorate and Regulatory Compliance Legislation/Guidelines for Comment/Implementation IT Upgrade Presentations Veterinary Medicines presentations Inspectorate Updates New...

SnerdCo via Adobe Stock

23 Feb SAHPRA Responds to Carte Blanche Report on Alleged GMP Non-compliance at Adcock Ingram Clayville Facility

Posted at 16:33h in News & Updates, Press Releases

Pretoria, 23 February 2026 – The South African Health Products Regulatory Authority (SAHPRA) has noted the recent Carte Blanche broadcast raising concerns, based on information from a former employee, regarding alleged Good Manufacturing Practice (GMP) non-compliance at Adcock Ingram’s manufacturing facility in Clayville, Johannesburg. SAHPRA wishes...